Bilimsel çalışmalar

Doç. Dr. Şafak Yıldırım Dişli

28 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön
  1. Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04842-3 PMID 41870760 Açık erişimli tam metinKaynak: OpenAlex

  2. Demographic Characteristics, Clinical Features, and Treatment Patterns of Classic and AIDS-Related Kaposi Sarcoma: A Multicenter Real-World Study from Turkey

    Medicina, 2026

    DOI 10.3390/medicina62081483 PMID 42654381 Açık erişimli tam metinKaynak: ORCID

  3. The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-44980-w PMID 41888201 Açık erişimli tam metinKaynak: OpenAlex

  4. The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor–positive, HER-2–negative metastatic breast cancer: A real-world, multicenter, retrospective study.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e24144 Kaynak: OpenAlex

  5. Efficacy of anti-VEGF & anti-EGFRs in microsatellite instable (MSI-H) metastatic colorectal cancer, Turkish Oncology Group (TOG) study.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e15507 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  6. Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

    Current Oncology, 2025

    DOI 10.3390/curroncol32110639 PMID 41294701 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  7. Second Line Therapies After Tyrosine Kinase Inhibitory in Metastatic Renal Cell Carcinoma

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2024.107988 Açık erişimli tam metinKaynak: OpenAlex

  8. AGE-RELATED OUTCOMES IN ELDERLY PATIENTS RECEIVING CDK4/6 INHIBITORS FOR HR+/HER2- METASTATIC BREAST CANCER: A RETROSPECTIVE MULTICENTER STUDY

    The Breast, 2025

    DOI 10.1016/s0960-9776(25)00723-4 Açık erişimli tam metinKaynak: OpenAlex

  9. Assessment of tumor location in adjuvant treatment decision for stage II colon cancer

    Anatolian Current Medical Journal, 2024

    DOI 10.38053/acmj.1482701 Açık erişimli tam metinKaynak: ORCID

  10. The Effect of Metformin on Survival in Patients with Non-Small Cell Lung Cancer

    Sağlık Bilimlerinde Değer, 2024

    DOI 10.33631/sabd.1216847 Açık erişimli tam metinKaynak: ORCID

  11. Prognostic Value of Inflammatory and Nutritional Index in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab in Second-Line Therapy

    International Journal of Hematology and Oncology, 2024

    DOI 10.4999/uhod.247680 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  12. Evaluation of digit ratio (2D:4D) in breast cancer patients

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-64692-3 PMID 38877071 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  13. Correlation of Temporal Muscle Thickness and Prognostic Nutritional Index with High-Grade Brain Tumor Progression

    Journal of Oncological Sciences, 2024

    DOI 10.37047/jos.2024-105121 Açık erişimli tam metinKaynak: ORCID

  14. Factors Effective in Persistent Penicillin Allergy

    Eurasian Journal of Medical Advances, 2024

    DOI 10.14744/ejma.2024.39306 Açık erişimli tam metinKaynak: ORCID

  15. Trends in the Incidence and Location of Gastric Cancers: A Single Center Experience

    Eurasian Journal of Medical Investigation, 2024

    DOI 10.14744/ejmi.2024.83699 1 atıf (OpenAlex) Kaynak: OpenAlex

  16. Does FDG PETCT have a predictive value for neoadjuvant chemotherapy response in nonmetastatic breast cancer?

    Irish Journal of Medical Science (1971 -), 2024

    DOI 10.1007/s11845-024-03856-6 PMID 39692805 Açık erişimli tam metinKaynak: OpenAlex

  17. HEMATOPOIETIC SYSTEM CANCERS

    Turkiye Klinikleri eBooks, 2024

    DOI 10.5336/978-625-395-393-5_p98 Kaynak: OpenAlex

  18. Evaluation of the relationship between toxicity of cyclin-dependent kinase 4/6 inhibitors and body surface area

    Revista da Associação Médica Brasileira, 2023

    DOI 10.1590/1806-9282.20230680 PMID 37971123 Açık erişimli tam metinKaynak: ORCID

  19. Onkolojide Moleküler Hedefli Tedaviler

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1478 Açık erişimli tam metinKaynak: OpenAlex

  20. Complementary and Alternative Treatment Use in Breast Cancer Patients in the Eastern Black Sea Region—A Cross-Sectional Study

    Indian Journal of Medical and Paediatric Oncology, 2022

    DOI 10.1055/s-0042-1749400 Açık erişimli tam metinKaynak: ORCID

  21. The association between the lymph node ratio, surgical margin, and survival in patients with colon cancer receiving adjuvant chemotherapy

    Pakistan Journal of Medical Sciences, 2022

    DOI 10.12669/pjms.38.3.5085 PMID 35480549 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  22. Toraks Tümörleri

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1073 Açık erişimli tam metinKaynak: OpenAlex

  23. Malign Melanomda Moleküler Hedefli Tedaviler

    2020

    Kaynak: OpenAlex

  24. Metastatik Driver Mutasyonu Olmayan Hastalıkta Sistemik Kemoterapi

    2019

    Kaynak: OpenAlex

  25. Fasting in Ramadan is not associated with deterioration of chronic kidney disease: A prospective observational study

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2017

    DOI 10.4103/1319-2442.198140 PMID 28098105 21 atıf (Europe PMC) Kaynak: ORCID

  26. Enterococcus faecalis endophthalmitis as a metastatic complication of hemodialysis vascular access-related sepsis: A case report and review of the literature

    Hemodialysis International, 2016

    DOI 10.1111/hdi.12356 PMID 26346615 6 atıf (Europe PMC) Kaynak: ORCID

  27. Hepatit B Yüzey Antijeni (Hbsag) Negatif, Hepatit B Yüzey Antikoru (AntiHbs) Pozitif Hastada Rituximab Tedavisi Sonrasında Hbv Reaktivasyonu Sonucunda Gelişen Akut Karaciğer Yetersizliği

    2016

    Kaynak: OpenAlex

  28. Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports

    Clinical Nephrology, 2015

    DOI 10.5414/cn108652 PMID 26558370 5 atıf (Europe PMC) Kaynak: ORCID